Eye Prophylaxis for Newborns

Newborn eye prophylaxis is the administration of antibiotic ointment into a newborn’s eyes shortly after birth to reduce the risk of ophthalmia neonatorum, also called neonatal conjunctivitis. This condition refers to conjunctivitis that occurs in the first weeks of life and can be caused by organisms acquired during birth, especially Neisseria gonorrhoeae and Chlamydia trachomatis. Public Health Ontario describes ophthalmia neonatorum as a bacterial eye infection passed from a birthing parent with gonorrhea or chlamydia during birth; symptoms can include red eyes, pus-like drainage, and swollen eyelids, and severe cases can rarely lead to blindness. For RPN practice, the key point is that eye prophylaxis is a routine newborn medication, but it is still a medication. The RPN must verify the order or medical directive, confirm the correct medication, administer it safely, monitor the newborn, document accurately, and escalate abnormal findings.